Cargando…

Efficacy of recombinant thrombomodulin for DIC after deceased donor liver transplantation: a case report

BACKGROUND: Disseminated intravascular coagulation (DIC) after liver transplantation (LT) is a difficult complication. We report a case of disseminated intravascular coagulation after deceased donor liver transplantation (DDLT) treated with recombinant thrombomodulin (rTM). CASE PRESENTATION: A 30-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Koichi, Yoshizumi, Tomoharu, Itoh, Shinji, Harimoto, Norifumi, Motomura, Takashi, Harada, Noboru, Nagatsu, Akihisa, Ikegami, Toru, Ninomiya, Mizuki, Soejima, Yuji, Maehara, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975734/
https://www.ncbi.nlm.nih.gov/pubmed/27495993
http://dx.doi.org/10.1186/s40792-016-0208-8
Descripción
Sumario:BACKGROUND: Disseminated intravascular coagulation (DIC) after liver transplantation (LT) is a difficult complication. We report a case of disseminated intravascular coagulation after deceased donor liver transplantation (DDLT) treated with recombinant thrombomodulin (rTM). CASE PRESENTATION: A 30-year-old woman underwent right tri-segment split graft DDLT for acute liver failure. She developed disseminated intravascular coagulation on post-operative day 5 with fever. Computed tomography revealed necrosis of hepatic segment IV, and her acute-phase disseminated intravascular coagulation score was seven points. She was given rTM, and the inflammation, liver function, and coagulation disorders immediately improved. However, pleural effusion drainage from the chest tube became bloody on post-operative day 11, and rTM was discontinued. She progressed well and was discharged from the hospital on post-operative day 28. rTM is an effective treatment for disseminated intravascular coagulation; however, rTM for cases with coagulation disorders, which can occur after liver transplantation, has both risks and benefits. CONCLUSIONS: We report a case of DIC after LT, in which rTM was potentially effective. Further studies are needed to determine the appropriate dosages, duration, and additional considerations for rTM therapy in liver transplantation patients.